Molecular Testing Markets for Infectious Diseases (Sepsis, Respiratory Diseases, HIV, Hepatitis, TB Testing, STIs and Other Tests)

Published: July 23, 2019 | Price: $4,500 – $9,000

Over half of the revenues earned in molecular diagnostics are earned by companies marketing tests to detect infectious disease. This Kalorama Information report examines the market opportunity for those tests, the companies that sell them, trends in the market and details segment-level market sizing and forecasts. Test Segments: Market Sizing and Forecasts There are several segments where testing at the molecular level has thrived, including the following: • HPV Testing • CT/NG Testing • Molecular Hepatitis Testing • HIV Testing...